{"id":196740,"name":"CONAFAY GROUP ON BEHALF OF ANTIBIOTICS WORKING GROUP","slug":"conafay-group-on-behalf-of-antibiotics-working-group","state":"NC","country":"United States of America","description":"Representing the voice of emerging antibiotics industry","totalSpending":1800000,"filings":33,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":340000},{"year":2020,"income":280000},{"year":2021,"income":280000},{"year":2022,"income":280000},{"year":2023,"income":170000},{"year":2024,"income":10000},{"year":2025,"income":200000}],"issues":["HCR"],"firms":["THE CONAFAY GROUP, LLC"],"lobbyists":["WILLIAM FRANCO","STEPHEN CONAFAY","EMILY WHEELER","DARIN GARDNER","JOSH NARROW","BRYAN SHUY"],"govEntities":["Food & Drug Administration (FDA)","HOUSE OF REPRESENTATIVES","SENATE","Health & Human Services, Dept of (HHS)","Centers For Medicare and Medicaid Services (CMS)","Executive Office of the President (EOP)"],"sampleDescriptions":["Legislation related to DISARM and R&D tax credit.","Legislation related to DISARM and R&D tax credit.","Legislation related to DISARM and R&D tax credit and biologics.","Legislation related to DISARM and R&D tax credit and biologics.","Legislation related to DISARM and R&D tax credit and biologics."],"years":[2018,2019,2020,2021,2022,2023,2024,2025]}